Intercept Pharma News - The fda turned down an intercept pharmaceuticals drug application for the fatty liver disease. Health regulator's staff reviewers on wednesday raised a string of concerns with intercept. Web i ntercept pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in. Web by frank vinluan on june 23, 2023.
The fda turned down an intercept pharmaceuticals drug application for the fatty liver disease. Health regulator's staff reviewers on wednesday raised a string of concerns with intercept. Web by frank vinluan on june 23, 2023. Web i ntercept pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in.